Other News

Physiomics plc is pleased to announce that it is participating in the American Association for Cancer Research Annual Meeting 2015, taking place at the Pennsylvania Convention Center, Philadelphia, Pennsylvania on 18-22 April 2015. Dr Frances Brightman will present on the application of the Virtual Tumour platform to predict agents targeting the PD-1/PD-L1 axis in combination with radiotherapy. ...

Read More

Dr Christophe Chassagnole will be speaking on Translational modelling of vemurafenib, selumetinib and docetaxel in metastatic melanoma with virtual tumour on Thursday 22nd January at 11:10am. For more information please visit www.pamm2015.com...

Read More

Physiomics will present a half-day workshop on “Applications of Physiomics’ Virtual Tumour Clinical within Translational Science”, on the June 10, 1:30 pm – 4:30 pm ahead of the 2014 PAGE meeting that will take place in Alicante (Spain). This workshop will review the preclinical Virtual Tumour model used to predict optimal doses and schedules of combination therapy. We will provide an overview regarding the extension...

Read More

Dr Hitesh Mistry has been accepted to present a posters at the Safety Pharmacology Society’s 13th Annual Meeting in, which will take place September 16-19 in Rotterdam, Netherlands. The poster entitled “Predicting Cardiac Toxicity from Data Generated via High-Throughput Screening” (#0023) will present the latest technology advances of the cardiac toxicity predictive platform developed at Physiomics. ...

Read More

Dr Eric Fernandez will present a poster on reducing animal experiments with the Virtual Tumour at the NC3Rs/Society of Biology 3Rs Symposium on the 19 June 2013 in London. The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) is an independent scientific organisation, which supports the UK science base by driving and funding innovation and technological developments that replace or...

Read More
})(jQuery)